Inhibition of EGFR phosphorylation in a panel of human breast cancer cells correlates with synergistic interactions between gefitinib and 5′-DFUR, the bioactive metabolite of Xeloda®
Maria Ait-Tihyaty, Zakaria Rachid, Catalin Mihalcioiu, Bertrand J. Jean-ClaudeVolume:
133
Language:
english
Pages:
10
DOI:
10.1007/s10549-011-1756-z
Date:
May, 2012
File:
PDF, 489 KB
english, 2012